Catalyst Capital Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Catalyst Capital Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-300,000	Closed	-$203K	–	633
2015 Q1	$203K	Hold	300,000	–	–	0.02%	278
2014 Q4	$237K	Buy	300,000 +68,200	+29%	+$46.6K	0.03%	296
2014 Q3	$108K	Hold	231,800	–	–	0.01%	315
2014 Q2	$116K	Buy	231,800 +156,800	+209%	+$75.8K	0.02%	318
2014 Q1	$24K	Hold	75,000	–	–	0.01%	308
2013 Q4	$26K	Sell	75,000 -5,000	-6%	-$6.04K	0.01%	252
2013 Q3	$162K	Hold	80,000	–	–	0.09%	231
2013 Q2	$154K	Buy	+80,000	New	+$141K	0.12%	191

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Catalyst Capital Advisors's GCVRZ Position: Q2 2015 in Review

Catalyst Capital Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 300,000 shares — an estimated $203K sold.

Catalyst Capital Advisors first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $237K in Q4 2014. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.

Catalyst Capital Advisors reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
Catalyst Capital Advisors sold 300,000 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $203K.
Catalyst Capital Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
Catalyst Capital Advisors's Sanofi Contingent Value Rights position peaked at $237K in Q4 2014.
116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.

Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.